Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hideya HAYASHI
FR901724, a Novel Anti-Human Immunodeficiency Virus (HIV) Peptide Produced by Streptomyces, Shows Synergistic Antiviral Activities With HIV Protease Inhibitor and 2',3'-Dideoxynucleosides.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Related publications
Crystal Structure of Human Immunodeficiency Virus (HIV) Type 2 Protease in Complex With a Reduced Amide Inhibitor and Comparison With HIV-1 Protease Structures.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor
Journal of Clinical Microbiology
Microbiology
Activities of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor Nelfinavir Mesylate in Combination With Reverse Transcriptase and Protease Inhibitors Against Acute HIV-1 Infection in Vitro.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Human Immunodeficiency Virus (HIV)
Human Immunodeficiency Virus (HIV)
Human Immunodeficiency Virus (HIV)
Transfusion Science
Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic in Vitro
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
DMP 323, a Nonpeptide Cyclic Urea Inhibitor of Human Immunodeficiency Virus (HIV) Protease, Specifically and Persistently Blocks Intracellular Processing of HIV Gag Polyprotein.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
12.1 Human Immunodeficiency Virus (HIV) —